Skip to main content
FinSpry Logo
FinSpry
PHAT logo
PHAT
(NASDAQ)
Phathom Pharmaceuticals, Inc.
$8.55-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Phathom Pharmaceuticals (PHAT) Stock Price & Financial Analysis

Phathom Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.47 - $8.82
52-Week High$18.31
52-Week Low$8.21
Open$8.61
Volume1.79M
Average Volume (3M)1.51M
Market Cap716.04M
Shares Outstanding83.75M
Price to Sales (P/S)2.99
Price to Book (P/B)-2.08
EV/EBITDA-19.06
Revenue (TTM)239.66M
Net Income (TTM)-99.07M
Free Cash Flow (TTM)-36.71M
EPS (TTM)$-1.27
Profit Margin-41.34%
Operating Margin-16.96%
50-Day MA$10.48
200-Day MA$12.52
52-Week Change-12.22%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Phathom Pharmaceuticals

What is the current stock price for PHAT?

As of the latest trading session, PHAT stock trades at $8.51. The 52-week range is $8.21–$18.31, with a day range of $8.46–$8.82.

What is the P/E ratio for PHAT?

The P/E ratio (Price-to-Earnings) for PHAT is shown in the Key Statistics section. This valuation metric helps compare Phathom Pharmaceuticals, Inc. to industry peers.

Does PHAT pay dividends?

Phathom Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PHAT?

Based on 4 analysts, the consensus for PHAT is Buy.

What is the market cap of PHAT?

Phathom Pharmaceuticals's market capitalization is $712.7M, classifying it as a small-cap company. Phathom Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.